Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2174-2184

  Mertz, J A ^a   Mustafa, F ^a   Meyers, S ^a   Dudley, J P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BREAST CELL; CELL SPECIFICITY; CONTROLLED STUDY; ENHANCER REGION; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA VIRUS; LONG TERMINAL REPEAT; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RAT; REPORTER GENE; T LYMPHOCYTE; VIRUS CARCINOGENESIS;

ANIMALS; BASE SEQUENCE; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENES, REPORTER; HUMANS; JURKAT CELLS; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; PROTO-ONCOGENE PROTEINS; RATS; RETROVIRIDAE; T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0035128104     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2174-2184.2001     Document Type: Article

References (70)

1. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1
2. The involvement of a type-B retrovirus in the induction of thymic lymphomas
3. Molecular biological characterization of a highly leukaemogenic virus isolated from the mouse. III. Identity with mouse mammary tumour virus
4. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus
5. Prolactin regulation of β-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line
6. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene
7. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences
8. Going the distance: A current view of enhancer action
9. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat
10. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses
11. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus
12. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: A reappraisal of the enhancer insertion model
13. Helixloop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers
14. Integration of type B retroviral DNA in virus-induced primary murine thymic lymphomas
15. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential
16. Thymotropism of murine leukemia virus is conferred by its long terminal repeat
17. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene
18. Amplification and novel locations of endogenous mouse mammary tumor virus genomes in mouse T-cell lymphomas
19. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor α2
20. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses
21. Alignment of U3 region sequences of mammalian type C viruses: Identification of highly conserved motifs and implications for enhancer design
22. Auto-inhibition and partner proteins, core-binding factor beta (CBFβ) and Ets-1, modulate DNA binding by CBFα2 (AML1)
23. Recombinant PCR
24. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat
25. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia
26. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friendmink cell focus-forming and Moloney murine leukemia viruses
27. A two-step mechanism for the interaction of estradiol with rat uterus
28. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wntl transgenic mice
29. Establishment and characterization of BALB/c lymphoma lines with B cell properties
30. Electroporation: Parameters affecting transfer of DNA into mammalian cells
31. Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus
32. Structural alterations in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice
33. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat
34. Core-binding factor influences the disease specificity of Moloney murine leukemia virus
35. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression
36. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia
37. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus
38. Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts
39. Sequence specificity of the core-binding factor
40. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: Interactions with the osteocalcin gene promoter
41. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
42. Lymphomas with acquired mouse mammary tumor virus proviruses resemble distinct prethymic and intrathymic phenotypes defined in vivo
43. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation
44. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia
45. Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias
46. Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice
47. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
48. Characterization of cell markers in type B retroviral-induced thymic lymphomas. I. Surface antigen phenotype and karyotype in developing and primary lymphomas
49. Relationship of B cell Fc receptors to T cell recognition of Mls antigen
50. Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation
51. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-L3
52. Insertional mutagenesis in mouse mammary tumorigenesis
53. Glandular epithelial cells from mice: A method for selective cultivation
54. - T cells
55. The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas
56. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences
57. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development
58. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer
59. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by CBF and Ets requires intact binding sites for both proteins
60. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers
61. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats
62. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-L3
63. Binding of SL3-L3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences
64. TRANSFAC: An integrated system for gene expression regulation
65. Cooperative binding of Ets-1 and core binding factor to DNA
66. Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas
67. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat
68. Transcriptional activity of core binding factor-α (AML1) and β subunits on murine leukemia virus enhancer cores
69. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-L3 in T lymphocytes
70. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland